ERIC VIVIER

Eric VIVIER

Eric VIVIER (c) JM Huron


Professor of Immunology at the Medical Faculty of Marseille and Hospital Practitioner, Eric Vivier is Director of the Centre of Immunology of Marseille-Luminy, where his team studies the cell biology of “Natural Killer” cells.

Veterinarian and immunologist by training, Eric Vivier is Director of the Centre d’Immunologie de Marseille-Luminy since 2006. In 1993, after a post-doctoral fellowship at Harvard Medical School, he joined the CIML where he founded the Laboratory “Natural Killer Cells and Innate Immunity” in 1996.

This research helped to elucidate the role  of this group of cells and more broadly to decipher the molecular mechanisms controlling  their activation.

Professor of Immunology at the Faculty of Medicine,  Hospital practitioner at the Timone Hospital and the Assistance-Publique Hospitals of Marseille, Eric Vivier opened the way for the development of new therapeutic strategies against cancer and inflammatory diseases.

He is one of the scientific founders of the biopharmaceutical company Innate Pharma, a pioneer of global immunotherapy.

Author of more than 230 publications to date, Eric Vivier has been engaged for many years in the development of research. Eric Vivier is a member of the Institut Universitaire de France, member of the scientific committee of the LNCC (French National League against Cancer), scientific advisor for the Institute of Hematology-Immunology-Pulmonology (INSERM) and member of the expert committee for the European Research Council (ERC) Starting Grant.